1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hospital-Treated Gram-Negative Infections Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 Klebsiella 1.2.3 Acinetobacter 1.2.4 Coli 1.2.5 cepacia 1.2.6 Pseudomonas 1.2.7 Serratia 1.2.8 Enterobacter 1.2.9 Others 1.3 Market by Application 1.3.1 Global Hospital-Treated Gram-Negative Infections Market Share by Application: 2020 VS 2026 1.3.2 Hospital 1.3.3 Lab 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hospital-Treated Gram-Negative Infections Market Perspective (2015-2026) 2.2 Global Hospital-Treated Gram-Negative Infections Growth Trends by Regions 2.2.1 Hospital-Treated Gram-Negative Infections Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Hospital-Treated Gram-Negative Infections Historic Market Share by Regions (2015-2020) 2.2.3 Hospital-Treated Gram-Negative Infections Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hospital-Treated Gram-Negative Infections Players by Market Size 3.1.1 Global Top Hospital-Treated Gram-Negative Infections Players by Revenue (2015-2020) 3.1.2 Global Hospital-Treated Gram-Negative Infections Revenue Market Share by Players (2015-2020) 3.2 Global Hospital-Treated Gram-Negative Infections Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Hospital-Treated Gram-Negative Infections Revenue 3.4 Global Hospital-Treated Gram-Negative Infections Market Concentration Ratio 3.4.1 Global Hospital-Treated Gram-Negative Infections Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hospital-Treated Gram-Negative Infections Revenue in 2019 3.5 Key Players Hospital-Treated Gram-Negative Infections Area Served 3.6 Key Players Hospital-Treated Gram-Negative Infections Product Solution and Service 3.7 Date of Enter into Hospital-Treated Gram-Negative Infections Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hospital-Treated Gram-Negative Infections Breakdown Data by Type (2015-2026) 4.1 Global Hospital-Treated Gram-Negative Infections Historic Market Size by Type (2015-2020) 4.2 Global Hospital-Treated Gram-Negative Infections Forecasted Market Size by Type (2021-2026) 5 Hospital-Treated Gram-Negative Infections Breakdown Data by Application (2015-2026) 5.1 Global Hospital-Treated Gram-Negative Infections Historic Market Size by Application (2015-2020) 5.2 Global Hospital-Treated Gram-Negative Infections Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Hospital-Treated Gram-Negative Infections Market Size (2015-2026) 6.2 North America Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020) 6.3 North America Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020) 6.4 North America Hospital-Treated Gram-Negative Infections Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Hospital-Treated Gram-Negative Infections Market Size (2015-2026) 7.2 Europe Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020) 7.3 Europe Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020) 7.4 Europe Hospital-Treated Gram-Negative Infections Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Hospital-Treated Gram-Negative Infections Market Size (2015-2026) 8.2 China Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020) 8.3 China Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020) 8.4 China Hospital-Treated Gram-Negative Infections Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Hospital-Treated Gram-Negative Infections Market Size (2015-2026) 9.2 Japan Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020) 9.3 Japan Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020) 9.4 Japan Hospital-Treated Gram-Negative Infections Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Hospital-Treated Gram-Negative Infections Market Size (2015-2026) 10.2 Southeast Asia Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020) 10.3 Southeast Asia Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020) 10.4 Southeast Asia Hospital-Treated Gram-Negative Infections Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Merck 11.1.1 Merck Company Details 11.1.2 Merck Business Overview 11.1.3 Merck Hospital-Treated Gram-Negative Infections Introduction 11.1.4 Merck Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020)) 11.1.5 Merck Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Pfizer Business Overview 11.2.3 Pfizer Hospital-Treated Gram-Negative Infections Introduction 11.2.4 Pfizer Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) 11.2.5 Pfizer Recent Development 11.3 AstraZeneca 11.3.1 AstraZeneca Company Details 11.3.2 AstraZeneca Business Overview 11.3.3 AstraZeneca Hospital-Treated Gram-Negative Infections Introduction 11.3.4 AstraZeneca Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) 11.3.5 AstraZeneca Recent Development 11.4 Abbott 11.4.1 Abbott Company Details 11.4.2 Abbott Business Overview 11.4.3 Abbott Hospital-Treated Gram-Negative Infections Introduction 11.4.4 Abbott Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) 11.4.5 Abbott Recent Development 11.5 Lupin Pharmaceuticals 11.5.1 Lupin Pharmaceuticals Company Details 11.5.2 Lupin Pharmaceuticals Business Overview 11.5.3 Lupin Pharmaceuticals Hospital-Treated Gram-Negative Infections Introduction 11.5.4 Lupin Pharmaceuticals Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) 11.5.5 Lupin Pharmaceuticals Recent Development 11.6 Istituto lusofarmaco d’italia 11.6.1 Istituto lusofarmaco d’italia Company Details 11.6.2 Istituto lusofarmaco d’italia Business Overview 11.6.3 Istituto lusofarmaco d’italia Hospital-Treated Gram-Negative Infections Introduction 11.6.4 Istituto lusofarmaco d’italia Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) 11.6.5 Istituto lusofarmaco d’italia Recent Development 11.7 Adelco S.A 11.7.1 Adelco S.A Company Details 11.7.2 Adelco S.A Business Overview 11.7.3 Adelco S.A Hospital-Treated Gram-Negative Infections Introduction 11.7.4 Adelco S.A Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) 11.7.5 Adelco S.A Recent Development 11.8 Zhejiang yuntao biotechnology co., Ltd 11.8.1 Zhejiang yuntao biotechnology co., Ltd Company Details 11.8.2 Zhejiang yuntao biotechnology co., Ltd Business Overview 11.8.3 Zhejiang yuntao biotechnology co., Ltd Hospital-Treated Gram-Negative Infections Introduction 11.8.4 Zhejiang yuntao biotechnology co., Ltd Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) 11.8.5 Zhejiang yuntao biotechnology co., Ltd Recent Development 11.9 Alcon Laboratories 11.9.1 Alcon Laboratories Company Details 11.9.2 Alcon Laboratories Business Overview 11.9.3 Alcon Laboratories Hospital-Treated Gram-Negative Infections Introduction 11.9.4 Alcon Laboratories Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) 11.9.5 Alcon Laboratories Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hospital-Treated Gram-Negative Infections Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Klebsiella Table 4. Key Players of Acinetobacter Table 5. Key Players of Coli Table 6. Key Players of cepacia Table 7. Key Players of Pseudomonas Table 8. Key Players of Serratia Table 9. Key Players of Enterobacter Table 10. Key Players of Others Table 11. Global Hospital-Treated Gram-Negative Infections Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 12. Global Hospital-Treated Gram-Negative Infections Market Size by Regions (US$ Million): 2020 VS 2026 Table 13. Global Hospital-Treated Gram-Negative Infections Market Size by Regions (2015-2020) (US$ Million) Table 14. Global Hospital-Treated Gram-Negative Infections Market Share by Regions (2015-2020) Table 15. Global Hospital-Treated Gram-Negative Infections Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 16. Global Hospital-Treated Gram-Negative Infections Market Share by Regions (2021-2026) Table 17. Hospital-Treated Gram-Negative Infections Market Market Trends Table 18. Hospital-Treated Gram-Negative Infections Market Drivers Table 19. Hospital-Treated Gram-Negative Infections Market Challenges Table 20. Hospital-Treated Gram-Negative Infections Market Restraints Table 21. Global Hospital-Treated Gram-Negative Infections Revenue by Players (2015-2020) (US$ Million) Table 22. Global Hospital-Treated Gram-Negative Infections Market Share by Players (2015-2020) Table 23. Global Top Hospital-Treated Gram-Negative Infections Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital-Treated Gram-Negative Infections as of 2019) Table 24. Global Hospital-Treated Gram-Negative Infections by Players Market Concentration Ratio (CR5 and HHI) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Hospital-Treated Gram-Negative Infections Product Solution and Service Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020) (US$ Million) Table 29. Global Hospital-Treated Gram-Negative Infections Market Size Share by Type (2015-2020) Table 30. Global Hospital-Treated Gram-Negative Infections Revenue Market Share by Type (2021-2026) Table 31. Global Hospital-Treated Gram-Negative Infections Market Size Share by Application (2015-2020) Table 32. Global Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020) (US$ Million) Table 33. Global Hospital-Treated Gram-Negative Infections Market Size Share by Application (2021-2026) Table 34. North America Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020) (US$ Million) Table 35. North America Hospital-Treated Gram-Negative Infections Market Share by Type (2015-2020) Table 36. North America Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020) (US$ Million) Table 37. North America Hospital-Treated Gram-Negative Infections Market Share by Application (2015-2020) Table 38. North America Hospital-Treated Gram-Negative Infections Market Size by Country (US$ Million) (2015-2020) Table 39. North America Hospital-Treated Gram-Negative Infections Market Share by Country (2015-2020) Table 40. Europe Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020) (US$ Million) Table 41. Europe Hospital-Treated Gram-Negative Infections Market Share by Type (2015-2020) Table 42. Europe Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020) (US$ Million) Table 43. Europe Hospital-Treated Gram-Negative Infections Market Share by Application (2015-2020) Table 44. Europe Hospital-Treated Gram-Negative Infections Market Size by Country (US$ Million) (2015-2020) Table 45. Europe Hospital-Treated Gram-Negative Infections Market Share by Country (2015-2020) Table 46. China Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020) (US$ Million) Table 47. China Hospital-Treated Gram-Negative Infections Market Share by Type (2015-2020) Table 48. China Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020) (US$ Million) Table 49. China Hospital-Treated Gram-Negative Infections Market Share by Application (2015-2020) Table 50. China Hospital-Treated Gram-Negative Infections Market Size by Region (US$ Million) (2015-2020) Table 51. China Hospital-Treated Gram-Negative Infections Market Share by Region (2015-2020) Table 52. Japan Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020) (US$ Million) Table 53. Japan Hospital-Treated Gram-Negative Infections Market Share by Type (2015-2020) Table 54. Japan Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020) (US$ Million) Table 55. Japan Hospital-Treated Gram-Negative Infections Market Share by Application (2015-2020) Table 56. Japan Hospital-Treated Gram-Negative Infections Market Size by Country (US$ Million) (2015-2020) Table 57. Japan Hospital-Treated Gram-Negative Infections Market Share by Country (2015-2020) Table 58. Southeast Asia Hospital-Treated Gram-Negative Infections Market Size by Type (2015-2020) (US$ Million) Table 59. Southeast Asia Hospital-Treated Gram-Negative Infections Market Share by Type (2015-2020) Table 60. Southeast Asia Hospital-Treated Gram-Negative Infections Market Size by Application (2015-2020) (US$ Million) Table 61. Southeast Asia Hospital-Treated Gram-Negative Infections Market Share by Application (2015-2020) Table 62. Southeast Asia Hospital-Treated Gram-Negative Infections Market Size by Country (US$ Million) (2015-2020) Table 63. Southeast Asia Hospital-Treated Gram-Negative Infections Market Share by Country (2015-2020) Table 64. Merck Company Details Table 65. Merck Business Overview Table 66. Merck Product Table 67. Merck Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) (US$ Million) Table 68. Merck Recent Development Table 69. Pfizer Company Details Table 70. Pfizer Business Overview Table 71. Pfizer Product Table 72. Pfizer Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) (US$ Million) Table 73. Pfizer Recent Development Table 74. AstraZeneca Company Details Table 75. AstraZeneca Business Overview Table 76. AstraZeneca Product Table 77. AstraZeneca Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) (US$ Million) Table 78. AstraZeneca Recent Development Table 79. Abbott Company Details Table 80. Abbott Business Overview Table 81. Abbott Product Table 82. Abbott Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) (US$ Million) Table 83. Abbott Recent Development Table 84. Lupin Pharmaceuticals Company Details Table 85. Lupin Pharmaceuticals Business Overview Table 86. Lupin Pharmaceuticals Product Table 87. Lupin Pharmaceuticals Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) (US$ Million) Table 88. Lupin Pharmaceuticals Recent Development Table 89. Istituto lusofarmaco d’italia Company Details Table 90. Istituto lusofarmaco d’italia Business Overview Table 91. Istituto lusofarmaco d’italia Product Table 92. Istituto lusofarmaco d’italia Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) (US$ Million) Table 93. Istituto lusofarmaco d’italia Recent Development Table 94. Adelco S.A Company Details Table 95. Adelco S.A Business Overview Table 96. Adelco S.A Product Table 97. Adelco S.A Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) (US$ Million) Table 98. Adelco S.A Recent Development Table 99. Zhejiang yuntao biotechnology co., Ltd Business Overview Table 100. Zhejiang yuntao biotechnology co., Ltd Product Table 101. Zhejiang yuntao biotechnology co., Ltd Company Details Table 102. Zhejiang yuntao biotechnology co., Ltd Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) (US$ Million) Table 103. Zhejiang yuntao biotechnology co., Ltd Recent Development Table 104. Alcon Laboratories Company Details Table 105. Alcon Laboratories Business Overview Table 106. Alcon Laboratories Product Table 107. Alcon Laboratories Revenue in Hospital-Treated Gram-Negative Infections Business (2015-2020) (US$ Million) Table 108. Alcon Laboratories Recent Development Table 109. Research Programs/Design for This Report Table 110. Key Data Information from Secondary Sources Table 111. Key Data Information from Primary Sources List of Figures Figure 1. Global Hospital-Treated Gram-Negative Infections Market Share by Type: 2020 VS 2026 Figure 2. Klebsiella Features Figure 3. Acinetobacter Features Figure 4. Coli Features Figure 5. cepacia Features Figure 6. Pseudomonas Features Figure 7. Serratia Features Figure 8. Enterobacter Features Figure 9. Others Features Figure 10. Global Hospital-Treated Gram-Negative Infections Market Share by Application: 2020 VS 2026 Figure 11. Hospital Case Studies Figure 12. Lab Case Studies Figure 13. Hospital-Treated Gram-Negative Infections Report Years Considered Figure 14. Global Hospital-Treated Gram-Negative Infections Market Size (US$ Million), YoY Growth 2015-2026 Figure 15. Global Hospital-Treated Gram-Negative Infections Market Share by Regions: 2020 VS 2026 Figure 16. Global Hospital-Treated Gram-Negative Infections Market Share by Regions (2021-2026) Figure 17. Global Hospital-Treated Gram-Negative Infections Market Share by Players in 2019 Figure 18. Global Top Hospital-Treated Gram-Negative Infections Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital-Treated Gram-Negative Infections as of 2019 Figure 19. The Top 10 and 5 Players Market Share by Hospital-Treated Gram-Negative Infections Revenue in 2019 Figure 20. North America Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. United States Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. Canada Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Europe Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Germany Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. France Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. U.K. Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Italy Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Russia Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Nordic Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Rest of Europe Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Asia-Pacific Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. China Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Japan Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. South Korea Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Southeast Asia Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. India Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Australia Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Rest of Asia-Pacific Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Latin America Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Mexico Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Brazil Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Middle East & Africa Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Turkey Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 44. Saudi Arabia Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 45. UAE Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 46. Rest of Middle East & Africa Hospital-Treated Gram-Negative Infections Market Size YoY Growth (2015-2026) & (US$ Million) Figure 47. Merck Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2015-2020) Figure 48. Pfizer Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2015-2020) Figure 49. AstraZeneca Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2015-2020) Figure 50. Abbott Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2015-2020) Figure 51. Lupin Pharmaceuticals Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2015-2020) Figure 52. Istituto lusofarmaco d’italia Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2015-2020) Figure 53. Adelco S.A Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2015-2020) Figure 54. Zhejiang yuntao biotechnology co., Ltd Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2015-2020) Figure 55. Alcon Laboratories Revenue Growth Rate in Hospital-Treated Gram-Negative Infections Business (2015-2020) Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Merck Pfizer AstraZeneca Abbott Lupin Pharmaceuticals Istituto lusofarmaco d’italia Adelco S.A Zhejiang yuntao biotechnology co., Ltd Alcon Laboratories